TREVENA INC
TRVN
Transaktioner
156
Köp
56
Sälj
100
Nettoinsynsflöde
-275 k USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
156 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 54 | 1,47 | 79 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 143 | 1,47 | 210 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 285 | 1,47 | 419 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 285 | 1,47 | 419 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 1 k | 1,47 | 2 k USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 20 | 1,47 | 29 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 45 | 1,47 | 66 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 144 | 1,47 | 212 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 144 | 1,47 | 212 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 532 | 1,47 | 782 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 17 | 1,47 | 25 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 41 | 1,47 | 60 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 130 | 1,47 | 191 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 130 | 1,47 | 191 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 488 | 1,47 | 717 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 54 | 1,47 | 79 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 143 | 1,47 | 210 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 285 | 1,47 | 419 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 285 | 1,47 | 419 USD |
| 2024-10-08 | Bourdow Carrie L. | Acting CEO | Sell | 1 k | 1,47 | 2 k USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 17 | 1,47 | 25 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 41 | 1,47 | 60 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 130 | 1,47 | 191 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 130 | 1,47 | 191 USD |
| 2024-10-08 | Shin Barry | Acting COO and CFO | Sell | 488 | 1,47 | 717 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 20 | 1,47 | 29 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 45 | 1,47 | 66 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 144 | 1,47 | 212 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 144 | 1,47 | 212 USD |
| 2024-10-08 | Demitrack Mark | Acting CMO | Sell | 532 | 1,47 | 782 USD |
| 2024-09-14 | Shin Barry | SVP, CFO | Sell | 3 | 5,95 | 18 USD |
| 2024-09-14 | Shin Barry | SVP, CFO | Sell | 3 | 5,95 | 18 USD |
| 2024-09-14 | Yoder Robert T | SVP, Chief Business Officer | Sell | 487 | 5,95 | 3 k USD |
| 2024-09-14 | Yoder Robert T | SVP, Chief Business Officer | Sell | 487 | 5,95 | 3 k USD |
| 2023-12-14 | Bourdow Carrie L. | President & CEO | Buy | 370 k | 0,61 | 226 k USD |
| 2023-12-14 | Bourdow Carrie L. | President & CEO | Buy | 100 k | 0,61 | 61 k USD |
| 2023-12-14 | Bourdow Carrie L. | President & CEO | Sell | 7 k | 0,61 | 4 k USD |
| 2023-12-14 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 185 k | 0,61 | 113 k USD |
| 2023-12-14 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 50 k | 0,61 | 31 k USD |
| 2023-12-14 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 4 k | 0,61 | 2 k USD |
| 2023-12-14 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 50 k | 0,61 | 31 k USD |
| 2023-12-14 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 25 k | 0,61 | 15 k USD |
| 2023-12-14 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 2 k | 0,61 | 1 k USD |
| 2023-12-14 | Shin Barry | SVP, CFO | Buy | 185 k | 0,61 | 113 k USD |
| 2023-12-14 | Shin Barry | SVP, CFO | Buy | 50 k | 0,61 | 31 k USD |
| 2023-12-14 | Shin Barry | SVP, CFO | Sell | 4 k | 0,61 | 2 k USD |
| 2023-12-14 | Yoder Robert T | SVP, Chief Business Officer | Buy | 93 k | 0,61 | 56 k USD |
| 2023-12-14 | Yoder Robert T | SVP, Chief Business Officer | Buy | 25 k | 0,61 | 15 k USD |
| 2023-12-14 | Yoder Robert T | SVP, Chief Business Officer | Sell | 2 k | 0,61 | 1 k USD |
| 2023-12-14 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 185 k | 0,61 | 113 k USD |
| 2023-12-14 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 50 k | 0,61 | 31 k USD |
| 2023-12-14 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 4 k | 0,61 | 2 k USD |
| 2023-12-14 | Shin Barry | SVP, CFO | Buy | 185 k | 0,61 | 113 k USD |
| 2023-12-14 | Shin Barry | SVP, CFO | Buy | 50 k | 0,61 | 31 k USD |
| 2023-12-14 | Shin Barry | SVP, CFO | Sell | 4 k | 0,61 | 2 k USD |
| 2023-12-14 | Bourdow Carrie L. | President & CEO | Buy | 370 k | 0,61 | 226 k USD |
| 2023-12-14 | Bourdow Carrie L. | President & CEO | Buy | 100 k | 0,61 | 61 k USD |
| 2023-12-14 | Bourdow Carrie L. | President & CEO | Sell | 7 k | 0,61 | 4 k USD |
| 2023-12-14 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 50 k | 0,61 | 31 k USD |
| 2023-12-14 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 25 k | 0,61 | 15 k USD |
| 2023-12-14 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 2 k | 0,61 | 1 k USD |
| 2023-12-14 | Yoder Robert T | SVP, Chief Business Officer | Buy | 93 k | 0,61 | 56 k USD |
| 2023-12-14 | Yoder Robert T | SVP, Chief Business Officer | Buy | 25 k | 0,61 | 15 k USD |
| 2023-12-14 | Yoder Robert T | SVP, Chief Business Officer | Sell | 2 k | 0,61 | 1 k USD |
| 2023-11-10 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 632 | 0,57 | 360 USD |
| 2023-11-10 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 632 | 0,57 | 360 USD |
| 2023-06-26 | Shin Barry | SVP, CFO | Sell | 722 | 0,84 | 606 USD |
| 2023-06-26 | Shin Barry | SVP, CFO | Sell | 722 | 0,84 | 606 USD |
| 2023-01-06 | Bourdow Carrie L. | President & CEO | Buy | 100 k | 0,00 | 0 USD |
| 2023-01-06 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 25 k | 0,00 | 0 USD |
| 2023-01-06 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 50 k | 0,00 | 0 USD |
| 2023-01-06 | Shin Barry | SVP, CFO | Buy | 50 k | 0,00 | 0 USD |
| 2023-01-06 | Yoder Robert T | SVP, Chief Business Officer | Buy | 25 k | 0,00 | 0 USD |
| 2023-01-06 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 50 k | 0,00 | 0 USD |
| 2023-01-06 | Bourdow Carrie L. | President & CEO | Buy | 100 k | 0,00 | 0 USD |
| 2023-01-06 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 25 k | 0,00 | 0 USD |
| 2023-01-06 | Shin Barry | SVP, CFO | Buy | 50 k | 0,00 | 0 USD |
| 2023-01-06 | Yoder Robert T | SVP, Chief Business Officer | Buy | 25 k | 0,00 | 0 USD |
| 2022-12-17 | Bourdow Carrie L. | President & CEO | Sell | 1 k | 1,55 | 2 k USD |
| 2022-12-17 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 497 | 1,55 | 770 USD |
| 2022-12-17 | Shin Barry | SVP, CFO | Sell | 413 | 1,55 | 640 USD |
| 2022-12-17 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 497 | 1,55 | 770 USD |
| 2022-12-17 | Yoder Robert T | SVP, Chief Business Officer | Sell | 443 | 1,55 | 687 USD |
| 2022-12-17 | Shin Barry | SVP, CFO | Sell | 413 | 1,55 | 640 USD |
| 2022-12-17 | Bourdow Carrie L. | President & CEO | Sell | 1 k | 1,55 | 2 k USD |
| 2022-12-17 | Yoder Robert T | SVP, Chief Business Officer | Sell | 443 | 1,55 | 687 USD |
| 2022-12-02 | Bourdow Carrie L. | President & CEO | Sell | 4 k | 3,42 | 12 k USD |
| 2022-12-02 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 1 k | 3,42 | 4 k USD |
| 2022-12-02 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 294 | 3,42 | 1 k USD |
| 2022-12-02 | Shin Barry | SVP, CFO | Sell | 1 k | 3,42 | 4 k USD |
| 2022-12-02 | Shin Barry | SVP, CFO | Sell | 1 k | 3,42 | 4 k USD |
| 2022-12-02 | Yoder Robert T | SVP, Chief Business Officer | Sell | 753 | 3,42 | 3 k USD |
| 2022-12-02 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 294 | 3,42 | 1 k USD |
| 2022-12-02 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 1 k | 3,42 | 4 k USD |
| 2022-12-02 | Bourdow Carrie L. | President & CEO | Sell | 4 k | 3,42 | 12 k USD |
| 2022-12-02 | Yoder Robert T | SVP, Chief Business Officer | Sell | 753 | 3,42 | 3 k USD |
| 2022-11-10 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 632 | 2,47 | 2 k USD |
| 2022-11-10 | Drake Patricia M. | SVP, Chief Commercial Officer | Sell | 632 | 2,47 | 2 k USD |
| 2022-09-14 | Shin Barry | SVP, CFO | Sell | 2 k | 0,21 | 369 USD |
| 2022-09-14 | Shin Barry | SVP, CFO | Sell | 2 k | 0,21 | 369 USD |
| 2022-06-28 | Shin Barry | SVP, CFO | Sell | 32 k | 0,41 | 13 k USD |
| 2022-06-28 | Shin Barry | SVP, CFO | Sell | 32 k | 0,41 | 13 k USD |
| 2021-12-17 | Bourdow Carrie L. | President & CEO | Sell | 34 k | 0,70 | 23 k USD |
| 2021-12-17 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 12 k | 0,70 | 9 k USD |
| 2021-12-17 | Shin Barry | SVP, CFO | Sell | 14 k | 0,70 | 10 k USD |
| 2021-12-17 | Shin Barry | SVP, CFO | Sell | 14 k | 0,70 | 10 k USD |
| 2021-12-17 | Yoder Robert T | SVP, Chief Business Officer | Sell | 10 k | 0,70 | 7 k USD |
| 2021-12-17 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 12 k | 0,70 | 9 k USD |
| 2021-12-17 | Bourdow Carrie L. | President & CEO | Sell | 34 k | 0,70 | 23 k USD |
| 2021-12-17 | Yoder Robert T | SVP, Chief Business Officer | Sell | 10 k | 0,70 | 7 k USD |
| 2021-12-06 | Bourdow Carrie L. | President & CEO | Sell | 94 k | 0,65 | 61 k USD |
| 2021-12-06 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 31 k | 0,65 | 20 k USD |
| 2021-12-06 | Shin Barry | SVP, CFO & CCO | Sell | 34 k | 0,65 | 22 k USD |
| 2021-12-06 | Bourdow Carrie L. | President & CEO | Sell | 94 k | 0,65 | 61 k USD |
| 2021-12-06 | Shin Barry | SVP, CFO & CCO | Sell | 34 k | 0,65 | 22 k USD |
| 2021-12-06 | Yoder Robert T | SVP, Chief Business Officer | Sell | 23 k | 0,65 | 15 k USD |
| 2021-12-06 | Demitrack Mark | SVP, Chief Medical Officer | Sell | 31 k | 0,65 | 20 k USD |
| 2021-12-06 | Yoder Robert T | SVP, Chief Business Officer | Sell | 23 k | 0,65 | 15 k USD |
| 2021-12-02 | Bourdow Carrie L. | President & CEO | Buy | 1.3 mn | 0,00 | 0 USD |
| 2021-12-02 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 390 k | 0,00 | 0 USD |
| 2021-12-02 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 100 k | 0,00 | 0 USD |
| 2021-12-02 | Shin Barry | SVP, CFO & CCO | Buy | 390 k | 0,00 | 0 USD |
| 2021-12-02 | Yoder Robert T | SVP, Chief Business Officer | Buy | 240 k | 0,00 | 0 USD |
| 2021-12-02 | Demitrack Mark | SVP, Chief Medical Officer | Buy | 390 k | 0,00 | 0 USD |
| 2021-12-02 | Bourdow Carrie L. | President & CEO | Buy | 1.3 mn | 0,00 | 0 USD |
| 2021-12-02 | Shin Barry | SVP, CFO & CCO | Buy | 390 k | 0,00 | 0 USD |
| 2021-12-02 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 100 k | 0,00 | 0 USD |
| 2021-12-02 | Yoder Robert T | SVP, Chief Business Officer | Buy | 240 k | 0,00 | 0 USD |
| 2021-11-10 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 215 k | 0,00 | 0 USD |
| 2021-11-10 | Drake Patricia M. | SVP, Chief Commercial Officer | Buy | 215 k | 0,00 | 0 USD |
| 2021-09-14 | Shin Barry | Chief Financial Officer | Buy | 28 k | 0,00 | 0 USD |
| 2021-09-14 | Shin Barry | Chief Financial Officer | Buy | 28 k | 0,00 | 0 USD |
| 2021-06-28 | Bourdow Carrie L. | President & CEO | Buy | 56 k | 1,79 | 101 k USD |
| 2021-06-28 | Bourdow Carrie L. | President & CEO | Buy | 56 k | 1,79 | 101 k USD |
| 2021-06-25 | Shin Barry | Chief Financial Officer | Sell | 25 k | 1,96 | 48 k USD |
| 2021-06-25 | Shin Barry | Chief Financial Officer | Sell | 25 k | 1,96 | 48 k USD |
| 2021-02-10 | Applebaum Scott | CLCO; SVP, Regulatory Affairs | Sell | 21 k | 2,85 | 60 k USD |
| 2021-02-10 | Applebaum Scott | CLCO; SVP, Regulatory Affairs | Sell | 21 k | 2,85 | 60 k USD |
| 2020-12-17 | Applebaum Scott | CLCO; SVP, Regulatory Affairs | Buy | 115 k | 0,00 | 0 USD |
| 2020-12-17 | Bourdow Carrie L. | President & CEO | Buy | 471 k | 0,00 | 0 USD |
| 2020-12-17 | Demitrack Mark | Sr. VP & Chief Medical Officer | Buy | 173 k | 0,00 | 0 USD |
| 2020-12-17 | Shin Barry | Chief Financial Officer | Buy | 157 k | 0,00 | 0 USD |
| 2020-12-17 | Shin Barry | Chief Financial Officer | Buy | 157 k | 0,00 | 0 USD |
| 2020-12-17 | Demitrack Mark | Sr. VP & Chief Medical Officer | Buy | 173 k | 0,00 | 0 USD |
| 2020-12-17 | Yoder Robert T | SVP, Chief Commercial Officer | Buy | 141 k | 0,00 | 0 USD |
| 2020-12-17 | Applebaum Scott | CLCO; SVP, Regulatory Affairs | Buy | 115 k | 0,00 | 0 USD |
| 2020-12-17 | Bourdow Carrie L. | President & CEO | Buy | 471 k | 0,00 | 0 USD |
| 2020-12-17 | Yoder Robert T | SVP, Chief Commercial Officer | Buy | 141 k | 0,00 | 0 USD |
| 2020-12-07 | Bourdow Carrie L. | President & CEO | Sell | 133 k | 2,27 | 302 k USD |
| 2020-12-07 | Demitrack Mark | Sr. VP & Chief Medical Officer | Sell | 49 k | 2,27 | 110 k USD |
| 2020-12-07 | Shin Barry | Chief Financial Officer | Sell | 42 k | 2,27 | 95 k USD |
| 2020-12-07 | Shin Barry | Chief Financial Officer | Sell | 42 k | 2,27 | 95 k USD |
| 2020-12-07 | Bourdow Carrie L. | President & CEO | Sell | 133 k | 2,27 | 302 k USD |
| 2020-12-07 | Demitrack Mark | Sr. VP & Chief Medical Officer | Sell | 49 k | 2,27 | 110 k USD |
| 2020-12-07 | Yoder Robert T | Sr VP Chief Commercial Officer | Sell | 37 k | 2,27 | 83 k USD |
| 2020-12-07 | Yoder Robert T | Sr VP Chief Commercial Officer | Sell | 37 k | 2,27 | 83 k USD |

